Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study.
van der Plas-Krijgsman WG, Giardiello D, Putter H, Steyerberg EW, Bastiaannet E, Stiggelbout AM, Mooijaart SP, Kroep JR, Portielje JEA, Liefers GJ, de Glas NA. van der Plas-Krijgsman WG, et al. Among authors: liefers gj. Lancet Healthy Longev. 2021 Nov;2(11):e704-e711. doi: 10.1016/S2666-7568(21)00229-4. Epub 2021 Nov 3. Lancet Healthy Longev. 2021. PMID: 36098027 Free article.
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
de Kruijf EM, van Nes JG, Sajet A, Tummers QR, Putter H, Osanto S, Speetjens FM, Smit VT, Liefers GJ, van de Velde CJ, Kuppen PJ. de Kruijf EM, et al. Among authors: liefers gj. Clin Cancer Res. 2010 Feb 15;16(4):1272-80. doi: 10.1158/1078-0432.CCR-09-1844. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145162
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients.
Hutteman M, Mieog JS, van der Vorst JR, Liefers GJ, Putter H, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL. Hutteman M, et al. Among authors: liefers gj. Breast Cancer Res Treat. 2011 May;127(1):163-70. doi: 10.1007/s10549-011-1419-0. Epub 2011 Mar 1. Breast Cancer Res Treat. 2011. PMID: 21360075 Free PMC article. Clinical Trial.
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer.
Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, Liefers GJ, Choi HS, Gibbs-Strauss SL, Putter H, Gioux S, Kuppen PJ, Ashitate Y, Löwik CW, Smit VT, Oketokoun R, Ngo LH, van de Velde CJ, Frangioni JV, Vahrmeijer AL. Mieog JS, et al. Among authors: liefers gj. Ann Surg Oncol. 2011 Sep;18(9):2483-91. doi: 10.1245/s10434-011-1566-x. Epub 2011 Mar 1. Ann Surg Oncol. 2011. PMID: 21360250 Free PMC article.
Lack of survival gain for elderly women with breast cancer.
Bastiaannet E, Portielje JE, van de Velde CJ, de Craen AJ, van der Velde S, Kuppen PJ, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, Westendorp RG, Liefers GJ. Bastiaannet E, et al. Among authors: liefers gj. Oncologist. 2011;16(4):415-23. doi: 10.1634/theoncologist.2010-0234. Epub 2011 Mar 15. Oncologist. 2011. PMID: 21406470 Free PMC article.
214 results